Astra Inks Oxford Vaccine Production Deal with China’s Kangtai

(Bloomberg) -- AstraZeneca Plc and China’s Shenzhen Kangtai Biological Products Co. entered a deal to produce the U.K. drugmaker’s promising Covid-19 vaccine, the latest in a flurry of global pacts...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.